Societe Generale Analysts Give Evonik Industries (EVK) a €40.00 Price Target

Societe Generale set a €40.00 ($46.51) price objective on Evonik Industries (FRA:EVK) in a research report released on Tuesday morning. The brokerage currently has a buy rating on the stock.

Several other research firms have also weighed in on EVK. Sanford C. Bernstein set a €35.00 ($40.70) price target on Evonik Industries and gave the company a buy rating in a report on Monday, September 24th. UBS Group set a €29.00 ($33.72) price target on Evonik Industries and gave the company a sell rating in a report on Monday, September 24th. Berenberg Bank set a €38.00 ($44.19) price target on Evonik Industries and gave the company a buy rating in a report on Friday, August 3rd. Independent Research set a €34.00 ($39.53) price target on Evonik Industries and gave the company a neutral rating in a report on Tuesday, August 7th. Finally, Deutsche Bank set a €40.00 ($46.51) price target on Evonik Industries and gave the company a buy rating in a report on Friday, August 3rd. Five research analysts have rated the stock with a sell rating, five have given a hold rating and twelve have assigned a buy rating to the stock. The company currently has an average rating of Hold and a consensus price target of €34.76 ($40.42).

FRA:EVK opened at €27.36 ($31.81) on Tuesday. Evonik Industries has a fifty-two week low of €26.78 ($31.14) and a fifty-two week high of €32.97 ($38.34).

About Evonik Industries

Evonik Industries AG engages in the specialty chemicals business worldwide. It operates through Nutrition & Care, Resource Efficiency, Performance Materials, and Services segments. The Nutrition & Care segment offers specialty chemicals, including amphoteric surfactants, ceramides, phytosphingosines, oleochemical quaternary derivatives, polyurethane additives, organically modified silicones, superabsorbents, amino acids and amino acid derivatives, synthesis products, pharmaceutical polymers, and DL-methionine for use in consumer goods, and animal nutrition and healthcare products.

See Also: Diversification in Investing

Analyst Recommendations for Evonik Industries (FRA:EVK)

Receive News & Ratings for Evonik Industries Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evonik Industries and related companies with MarketBeat.com's FREE daily email newsletter.


Leave a Reply